Amicus Therapeutics, Inc. Logo Image

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. Banner Image

Most Recent Annual Report

2019 Annual Report and Form 10K

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Amicus Therapeutics, Inc.

501-1000 Employees
Based in Cranbury, New Jersey

Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare metabolic diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a robust pipeline of cutting-edge, first- or best-in-class medicines for rare metabolic diseases.

NASDAQ (See More NASDAQ Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol